Skip to main content
. Author manuscript; available in PMC: 2022 May 19.
Published in final edited form as: Circulation. 2016 Aug 2;134(5):422–431. doi: 10.1161/CIRCULATIONAHA.116.022061

Table 3.

Research Priorities in the Higher-Risk CAD Population Potentially Eligible for PCi

Research Priority/Question Study design/Cohort
What is the prevalence of severe (and nonrevascularized) CAD? Disease-based (as opposed to solely procedure-based) registries
What are the outcomes of PCI in higher-risk CAD patients (eg, nonsurgical patients), and are there specific operator/institution volumes that are required to achieve the best procedural outcomes? Procedural registries
What are the costs associated with revascularization in higher-risk CAD patients? Dedicated cost-effectiveness studies within procedure- and disease-based registries
What are the outcomes with PCI, surgical revascularization, and medical therapy among higher-risk patients with an indication for revascularization? Disease-based registries with embedded procedural data Potential randomized trials
What is the variability in care patterns for patients meriting consideration of revascularization? Disease-based registries with embedded procedural data
To what extent are contemporary interventionalists trained and skilled to perform complete revascularization across complex lesion subsets? Procedure- and disease-based registries
To what extent can PCI achieve surgery-like outcomes in higher-risk CAD patients? Randomized trials, possible comparative-effectiveness assessments

CAD indicates coronary artery disease; and PCI, percutaneous coronary intervention.